Amy DeLuca

505 total citations
15 papers, 397 citations indexed

About

Amy DeLuca is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Amy DeLuca has authored 15 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Amy DeLuca's work include Cancer-related cognitive impairment studies (5 papers), Advanced MRI Techniques and Applications (4 papers) and Functional Brain Connectivity Studies (3 papers). Amy DeLuca is often cited by papers focused on Cancer-related cognitive impairment studies (5 papers), Advanced MRI Techniques and Applications (4 papers) and Functional Brain Connectivity Studies (3 papers). Amy DeLuca collaborates with scholars based in United States, Australia and Spain. Amy DeLuca's co-authors include Reisa A. Sperling, Kelly O’Keefe, Brad C. Dickerson, Pete LaViolette, Deborah Blacker, Hope S. Rugo, Michelle Melisko, Alireza Atri, Dorene M. Rentz and Jacqueline O’Brien and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Amy DeLuca

13 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy DeLuca United States 7 209 133 114 63 59 15 397
Kristin Taylor United States 7 94 0.4× 96 0.7× 132 1.2× 34 0.5× 47 0.8× 14 373
Camila de Godoi Carneiro Brazil 11 162 0.8× 49 0.4× 75 0.7× 24 0.4× 95 1.6× 33 382
Pantelis Stathis Greece 14 118 0.6× 65 0.5× 35 0.3× 57 0.9× 31 0.5× 36 565
Li Cai China 11 68 0.3× 90 0.7× 112 1.0× 13 0.2× 42 0.7× 23 303
Hyeon Jin Kim South Korea 13 96 0.5× 98 0.7× 36 0.3× 15 0.2× 42 0.7× 32 332
Walter Haindl Australia 8 105 0.5× 84 0.6× 23 0.2× 28 0.4× 93 1.6× 20 319
Tetsuichi Asano Japan 8 118 0.6× 100 0.8× 117 1.0× 8 0.1× 181 3.1× 12 416
Pierre Branger France 6 145 0.7× 52 0.4× 51 0.4× 12 0.2× 68 1.2× 15 350
Simona Petrucci Italy 16 61 0.3× 99 0.7× 135 1.2× 82 1.3× 32 0.5× 43 755
Vasilios C. Constantinides Greece 15 64 0.3× 153 1.2× 208 1.8× 21 0.3× 38 0.6× 71 620

Countries citing papers authored by Amy DeLuca

Since Specialization
Citations

This map shows the geographic impact of Amy DeLuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy DeLuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy DeLuca more than expected).

Fields of papers citing papers by Amy DeLuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy DeLuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy DeLuca. The network helps show where Amy DeLuca may publish in the future.

Co-authorship network of co-authors of Amy DeLuca

This figure shows the co-authorship network connecting the top 25 collaborators of Amy DeLuca. A scholar is included among the top collaborators of Amy DeLuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy DeLuca. Amy DeLuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Apple, Alexandra C., Cutter A. Lindbergh, Susan Landau, et al.. (2022). Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer. Journal of Oncology. 2022. 1–9.
2.
Melisko, Michelle, et al.. (2019). Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease. Breast Cancer Research and Treatment. 177(2). 401–408. 20 indexed citations
3.
Hoeve, Elizabeth S. Ver, et al.. (2017). Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment. 167(1). 117–122. 24 indexed citations
4.
Vidula, Neelima, Jimmy Hwang, Sally Greenberg, et al.. (2017). Long term follow up (LTFU) of adjuvant zoledronic acid (ZOL) in high risk early stage breast cancer (ESBC) defined by bone marrow (BM) disseminated tumor cells (DTC).. Journal of Clinical Oncology. 35(15_suppl). e12001–e12001. 1 indexed citations
5.
Magbanua, Mark Jesus M., Lisa A. Carey, Amy DeLuca, et al.. (2014). Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers. Clinical Cancer Research. 21(5). 1098–1105. 32 indexed citations
6.
Rugo, Hope S., Amy DeLuca, Lara Heflin, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.. Journal of Clinical Oncology. 31(26_suppl). 104–104. 2 indexed citations
7.
Heflin, Lara, Amy DeLuca, Michelle Melisko, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.. Journal of Clinical Oncology. 31(15_suppl). 6619–6619.
8.
Heflin, Lara, Amy DeLuca, Michelle Melisko, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.. Journal of Clinical Oncology. 31(26_suppl). 105–105. 1 indexed citations
9.
Rugo, Hope S., Amy DeLuca, Lara Heflin, et al.. (2013). Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.. Journal of Clinical Oncology. 31(15_suppl). 6620–6620. 3 indexed citations
10.
McLaren, Donald G., Aishwarya Sreenivasan, Eli L. Diamond, et al.. (2012). Tracking Cognitive Change over 24 Weeks with Longitudinal Functional Magnetic Resonance Imaging in Alzheimer’s Disease. Neurodegenerative Diseases. 9(4). 176–186. 40 indexed citations
11.
Atri, Alireza, Jacqueline O’Brien, Aishwarya Sreenivasan, et al.. (2011). Test-Retest Reliability of Memory Task Functional Magnetic Resonance Imaging in Alzheimer Disease Clinical Trials. Archives of Neurology. 68(5). 599–606. 29 indexed citations
12.
O’Keefe, Kelly, Pete LaViolette, Amy DeLuca, et al.. (2010). Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 74(24). 1969–1976. 235 indexed citations
15.
Sperling, Reisa A., Jacqueline O’Brien, Kelly O’Keefe, et al.. (2008). P1‐295: Longitudinal functional MRI demonstrates loss of hippocampal activation associated with clinical decline in nondemented older subjects. Alzheimer s & Dementia. 4(4S_Part_9). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026